Matches in Nanopublications for { ?s ?p "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1116294.RAXl4swnJA5ChwzS7WmmyyOm_tSKlEfbfxZFECP_LwXzA130_assertion description "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116294.RAXl4swnJA5ChwzS7WmmyyOm_tSKlEfbfxZFECP_LwXzA130_provenance.
- assertion description "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP930036.RAFEaI7fUsN1ZFPfqvbrcwqPzXgDQFOI1Vj0L62aKhRUo130_assertion description "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930036.RAFEaI7fUsN1ZFPfqvbrcwqPzXgDQFOI1Vj0L62aKhRUo130_provenance.
- NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_assertion description "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- NP930035.RAxaJsMVFX_9dUgTIyPTbq1nke4gcZiGZVFVJbQLtRVvM130_assertion description "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930035.RAxaJsMVFX_9dUgTIyPTbq1nke4gcZiGZVFVJbQLtRVvM130_provenance.